We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

167 hedge funds and large institutions have $1.39B invested in Aerie Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 60 increasing their positions, 47 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $17.2M | Put options by funds: $6.21M

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

28% more capital invested

Capital invested by funds: $1.09B → $1.39B (+$304M)

28% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 47

0% more funds holding

Funds holding: 167 → 167 (0)

0% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 36

Holders
167
Holders Change
–
Holders Change %
0%
% of All Funds
3.29%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.16%
New
36
Increased
60
Reduced
47
Closed
36
Calls
$17.2M
Puts
$6.21M
Net Calls
+$11M
Net Calls Change
+$1.8M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$23.7M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$22.8M
3
Bank of America
Bank of America
North Carolina
+$22.8M
4
Citigroup
Citigroup
New York
+$19.1M
5
PHS
PFM Health Sciences
California
+$12.1M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$57.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$27.2M
3
WRF
Waddell & Reed Financial
Kansas
-$20.3M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.5M
5
Goldman Sachs
Goldman Sachs
New York
-$7.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
Daiwa Securities Group
151
Daiwa Securities Group
Japan
$6K -$580 -28 -10%
PHK
152
Point72 Hong Kong
Hong Kong
$6K +$5.38K +260 New
ASN
153
Advisory Services Network
Georgia
$6K +$5.41K +261 New
US Bancorp
154
US Bancorp
Minnesota
$5K -$1.26K -61 -22%
LJHT
155
Laurie J. Hall Trustee
$5K +$828 +40 +25%
PNC Financial Services Group
156
PNC Financial Services Group
Pennsylvania
$5K +$3.31K +160 +364%
Northwestern Mutual Wealth Management
157
Northwestern Mutual Wealth Management
Wisconsin
$4K -$2.9K -140 -47%
BCA
158
Berman Capital Advisors
Georgia
$4K – – –
MCM
159
Manchester Capital Management
Vermont
$4K – – –
Carson Wealth (CWM LLC)
160
Carson Wealth (CWM LLC)
Nebraska
$3K – – –
WAP
161
Wealthcare Advisory Partners
Pennsylvania
$3K +$2.59K +125 New
QCG
162
Quadrant Capital Group
Ohio
$2K – – –
MAM
163
Meeder Asset Management
Ohio
$1K -$26.8K -1,293 -96%
SFS
164
Sowell Financial Services
Arkansas
$1K +$642 +31 New
PCG
165
Private Capital Group
Connecticut
$1K +$1.08K +52 New
OPS
166
Orion Portfolio Solutions
Nebraska
$1K +$1.2K +58 New
Point72 Asset Management
167
Point72 Asset Management
Connecticut
– -$27.2M -1,412,759 Closed
Adage Capital Partners
168
Adage Capital Partners
Massachusetts
– -$7.5M -390,100 Closed
PIM
169
Provident Investment Management
Michigan
– -$7.13M -371,174 Closed
Prudential Financial
170
Prudential Financial
New Jersey
– -$5.73M -282,000 Closed
Balyasny Asset Management
171
Balyasny Asset Management
Illinois
– -$4.9M -255,164 Closed
AC
172
Aristeia Capital
Connecticut
– -$2.91M -151,350 Closed
ACPU
173
Arrowgrass Capital Partners (US)
Delaware
– -$2.91M -151,350 Closed
LA
174
Linden Advisors
New York
– -$2.88M -149,768 Closed
BAMCO Inc
175
BAMCO Inc
New York
– -$2.71M -141,194 Closed
5 6
7
8 9

AERI Hedge Fund Activity: Q4 2019 in Review

167 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2019, worth a combined $1.39B — up 28% from $1.09B a quarter earlier.

Fund positioning in AERI was balanced in Q4 2019: 36 funds opened new positions, 36 closed out, 60 added to existing stakes and 47 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $23.7M. The largest seller was Deerfield Management, cutting an estimated $57.9M.

  • 167 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $1.39B of Aerie Pharmaceuticals stock for Q4 2019, up 28% quarter-over-quarter.
  • 36 funds opened new Aerie Pharmaceuticals positions in Q4 2019 and 36 closed out, a net change of 0 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2019 was Franklin Resources, an estimated $23.7M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2019 was Deerfield Management, an estimated $57.9M sold.

Based on aggregated 13F filings for Q4 2019.